Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).

Saifuddin M, Paul AK, Shefin SM, Alam MJ, Selim S, Islam S, Hossain T, Tuqan S, Sultana N, Mustari M, Basak RC, Aftab KA, Prasad I, Uddin MR, Sharker S, Gaffar MAJ, Rahman MM, Hannan MA, Ahammed A, Kamrul-Hasan A

Open source

DOI: 10.4103/ijem.ijem_189_23
Published: 2024 Sep-Oct
Container: Indian journal of endocrinology and metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4103/ijem.ijem_189_23,
  title = {Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).},
  author = {Saifuddin M and Paul AK and Shefin SM and Alam MJ and Selim S and Islam S and Hossain T and Tuqan S and Sultana N and Mustari M and Basak RC and Aftab KA and Prasad I and Uddin MR and Sharker S and Gaffar MAJ and Rahman MM and Hannan MA and Ahammed A and Kamrul-Hasan A},
  year = {2024},
  journal = {Indian journal of endocrinology and metabolism},
  doi = {10.4103/ijem.ijem_189_23},
  url = {https://doi.org/10.4103/ijem.ijem_189_23}
}

RIS

TY  - JOUR
TI  - Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).
AU  - Saifuddin M
AU  - Paul AK
AU  - Shefin SM
AU  - Alam MJ
AU  - Selim S
AU  - Islam S
AU  - Hossain T
AU  - Tuqan S
AU  - Sultana N
AU  - Mustari M
AU  - Basak RC
AU  - Aftab KA
AU  - Prasad I
AU  - Uddin MR
AU  - Sharker S
AU  - Gaffar MAJ
AU  - Rahman MM
AU  - Hannan MA
AU  - Ahammed A
AU  - Kamrul-Hasan A
PY  - 2024
JO  - Indian journal of endocrinology and metabolism
DO  - 10.4103/ijem.ijem_189_23
UR  - https://doi.org/10.4103/ijem.ijem_189_23
ER  -

APA

M, S., AK, P., SM, S., MJ, A., S, S., S, I., T, H., S, T., N, S., M, M., RC, B., KA, A., I, P., MR, U., S, S., MAJ, G., MM, R., MA, H., A, A., & A, K. (2024). Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).. Indian journal of endocrinology and metabolism. https://doi.org/10.4103/ijem.ijem_189_23

Source records

pubmed · retrieved 2026-09-27T11:23:20.956Z